DxTerity Diagnostics Inc. products

Autoimmune diseases need analysis tools that go beyond superficial symptoms to recognize the distinct immune system activity of each patient.  Modular transcriptome repertoire analysis ¹, also known as modular genomics, shows tremendous promise for improving the characterization of patients with autoimmune diseases such as Systemic Lupus Erythematosus (SLE)⁷, Multiple Sclerosis (MS), Inflammatory Bowel Disease (IBD), and Rheumatoid Arthritis (RA) by providing biological insight into the underpinnings of a patient’s disease and how interrelated immune pathways change in response to treatment.

SLE Monitor combines three widely used biomarkers of SLE disease activity with the DxTerity IFN-1 test.  The SLE Monitor Test is undergoing evaluation as a "from home" test.  Check back for information about enrolling in the ELEVATE clinical study.

DxTerity’s IFN-1 Test uses a simple fingerstick blood collection conducted at your doctor`s office. Measure your IFN-1 levels and know your risks for SLE disease progression. Take back control of your health.

COVID-19 is caused by the SARS-CoV-2 virus which is a new virus in humans causing a contagious respiratory illness. COVID-19 can present with a mild to severe illness, although some people infected with COVID-19 may have no symptoms at all. Older adults and people of any age who have underlying medical conditions have a higher risk of severe illness from COVID-19. Serious outcomes of COVID-19 include hospitalization and death. The SARS-CoV-2 virus can be spread to others not just while one is sick, but even before a person shows signs or symptoms of being sick (e.g., fever, coughing, difficulty breathing, etc.).